Form 4 for MAGN Magnera Corp
Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-04 · accession 0001127602-24-026637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-06 | 2024-11-04 | MAGN | Urey Jill L. | EVP, GC, Corp Sec | F - Tax | $21.05 | -275 | 1,615 | -15% | -$5,789 |
| DM | 2024-11-06 | 2024-11-04 | MAGN | Urey Jill L. | EVP, GC, Corp Sec | A - Grant | $21.05 | +971 | 1,020 | +1,982% | +$20.4K |
| DM | 2024-11-06 | 2024-11-04 | MAGN | Urey Jill L. | EVP, GC, Corp Sec | A - Grant | $0.00 | +14.3K | 9,501 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, Par Value $.01 | 2024-11-04 | F | D | 30 | $21.05 | 990 | D | — | — | (F2) These shares are being withheld to satisfy tax obligations. |
| 2 | Common | Common Stock, Par Value $.01 | 2024-11-04 | F | D | 245 | $21.05 | 1,615 | D | — | — | (F2) These shares are being withheld to satisfy tax obligations. (F4) Represents shares of Magnera Corporation (formerly Glatfelter Corporation, "the Issuer") common stock, par value $0.01 per share, after giving effect to a 1-for-13 reverse stock split effective on November 4, 2024 and the subsequent vesting of Performance Shares reported above. |
| 3 | Common | Common Stock, Par Value $.01 | 2024-11-04 | A | A | 870 | $21.05 | 1,860 | D | — | — | (F3) These shares were received in settlement of a Performance Share Award granted on February 24, 2023. In connection with a series of transactions pursuant to which a wholly-owned subsidiary of the Issuer combined with Berry Global Group Inc.'s global nonwovens and hygiene films business in a Reverse Morris Trust transaction (collectively, the "Transactions"), outstanding performance stock awards ("PSAs") held by executive officers of the Issuer that were outstanding immediately prior to the Transactions vested upon the closing of the Transactions, and, as a result, were deemed to be earned and vested at (i) actual performance for completed performance periods, and (ii) target performance through the date of the Transactions for incomplete performance periods. |
| 4 | Common | Common Stock, Par Value $.01 | 2024-11-04 | A | A | 101 | $21.05 | 1,020 | D | — | — | (F1) These shares were received in settlement of a Performance Share Award granted on February 18, 2022. In connection with a series of transactions pursuant to which a wholly-owned subsidiary of the Issuer combined with Berry Global Group Inc.'s global nonwovens and hygiene films business in a Reverse Morris Trust transaction (collectively, the "Transactions"), outstanding performance stock awards ("PSAs") held by executive officers of the Issuer that were outstanding immediately prior to the Transactions vested upon the closing of the Transactions, and, as a result, were deemed to be earned and vested at (i) actual performance for completed performance periods, and (ii) target performance through the date of the Transactions for incomplete performance periods. |
| 5 | Derivative | Restricted Stock Units | 2024-11-04 | A | A | 4,750 | $0.00 | 4,750 | D | — · 2025-11-04 to 2027-11-04 | 4,750 Common Stock, Par Value $.01 | (F5) Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. (F6) This grant vests one-third 11/4/2025, one-third 11/4/2026 and one-third 11/4/2027. This grant vests in full, and all restrictions lapse, three years from the Grant Date. |
| 6 | Derivative | Restricted Stock Units | 2024-11-04 | A | A | 9,501 | $0.00 | 9,501 | D | — · 2027-11-04 to 2027-11-04 | 9,501 Common Stock, Par Value $.01 | (F5) Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. (F7) This grant vests in full and all restrictions lapse three years from the Grant Date, subject to the individual's continuous employment with Magnera Corporation. |